Tevogen Inc. Diluted Shares Outstanding (Weighted Average)
Tevogen Inc. (TVGN) reported Diluted Shares Outstanding (Weighted Average) of 3.83 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-14
- Tevogen Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 3.83M shares, a 16.29% increase year-over-year.
- Tevogen Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 3.49M shares, a 7.99% increase year-over-year.
- Tevogen Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was -547.98M shares.
- Tevogen Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 196.03M shares, a 15.19% increase year-over-year.
- Tevogen Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 3.32M shares, a 13.17% increase from fiscal 2024.
- Tevogen Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 2.93M shares, a 88.15% decline from fiscal 2023.
- Tevogen Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 24.75M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 5 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.83M shares 10-Q · filed 2026-08-14 | 3.66M shares 10-Q · filed 2026-08-14 | -180.22M shares derived: average of 3 quarters · filed 2026-08-14 | -86.16M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 3.49M shares 10-Q · filed 2026-05-15 | -272.25M shares derived: average of 2 quarters · filed 2026-05-15 | -116.16M shares derived: average of 3 quarters · filed 2026-05-15 | -86.29M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -547.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -175.98M shares derived: average of 2 quarters · filed 2026-03-31 | -116.22M shares derived: average of 3 quarters · filed 2026-08-14 | 3.32M shares 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 196.03M shares 10-Q · filed 2025-11-14 | 99.66M shares derived: average of 2 quarters · filed 2026-08-14 | 187.09M shares 10-Q · filed 2025-11-14 | -66.43M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 3.29M shares 10-Q · filed 2026-08-14 | 184.31M shares 10-Q · filed 2025-08-14 | 3.26M shares 10-Q · filed 2026-08-14 | 182.54M shares 10-Q · filed 2025-08-14 | -153.92M shares derived: average of 3 quarters · filed 2026-08-14 | -72.89M shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | 3.23M shares 10-Q · filed 2026-05-15 | 161.41M shares 10-Q · filed 2025-05-14 | -232.52M shares derived: average of 2 quarters · filed 2026-05-15 | -98.29M shares derived: average of 3 quarters · filed 2026-05-15 | -35.17M shares derived: average of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | -468.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -149.05M shares derived: average of 2 quarters · filed 2026-03-31 | -47.98M shares derived: average of 3 quarters · filed 2026-03-31 | 2.93M shares 10-K · filed 2026-03-31 | 146.67M shares 10-K · filed 2025-04-02 | |||
| 2024-09-30 | 170.17M shares 10-Q · filed 2025-11-14 | 162.17M shares derived: average of 2 quarters · filed 2025-11-14 | 160.00M shares 10-Q · filed 2025-11-14 | 122.87M shares derived: average of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | 154.17M shares 10-Q · filed 2025-08-14 | 148.15M shares 10-Q · filed 2025-08-14 | 107.10M shares derived: average of 3 quarters · filed 2025-08-14 | 110.33M shares derived: average of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | 142.39M shares 10-Q · filed 2025-05-14 | 83.57M shares derived: average of 2 quarters · filed 2025-05-14 | 95.71M shares derived: average of 3 quarters · filed 2025-05-14 | 101.78M shares derived: average of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | 24.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | 72.38M shares derived: average of 2 quarters · filed 2025-04-02 | 88.25M shares derived: average of 3 quarters · filed 2025-04-02 | 24.75M shares 10-K · filed 2025-04-02 | ||||
| 2023-09-30 | 120.00M shares 10-Q · filed 2024-11-19 | 120.00M shares derived: average of 2 quarters · filed 2024-11-19 | 24.75M shares 10-Q · filed 2024-11-19 | |||||
| 2023-06-30 | 120.00M shares 10-Q · filed 2024-08-14 | 120.00M shares 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | 120.00M shares 10-Q · filed 2024-05-28 | |||||||
| 2022-03-31 | 35.95M shares 10-Q · filed 2023-05-22 | |||||||
| 2021-09-30 | 10.32M shares 10-Q · filed 2021-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B |